The following articles (labelled with PubMed ID or TBD) are for your review
| PMID | Data | Article Title | Organization |
|---|
| 26256053 |
13 |
The N-Terminal T-T Motif of a Third-Generation HIV-1 Fusion Inhibitor Is Not Required for Binding Affinity and Antiviral Activity. |
Chinese Academy of Medical Sciences & Peking Union Medical College |
| 19949058 |
15 |
Blockade of X4-tropic HIV-1 cellular entry by GSK812397, a potent noncompetitive CXCR4 receptor antagonist. |
Glaxosmithkline |
| | 6 |
Structure-directed discovery of an inhibitor of the binding of HIV GP120 to the CD4 receptor |
TBA |
| | 1 |
β-Lactam peptides as potential inhibitors of the HIV gp120-CD4 interaction |
TBA |
| 10843204 |
1 |
Synthesis of glycolipid analogues that disrupt binding of HIV-1 gp120 to galactosylceramide. |
Cornell University |
| 10639280 |
101 |
Design and structure-activity relationship of a new class of potent VEGF receptor tyrosine kinase inhibitors. |
Astrazeneca |
| 12408711 |
112 |
Identification of potent and selective small-molecule inhibitors of caspase-3 through the use of extended tethering and structure-based drug design. |
Sunesis Pharmaceuticals |
Search and Browse
